Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:7128909.
doi: 10.1155/2016/7128909. Epub 2016 Jun 28.

Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission

Faizan Mazhar  1 , Shahzad Akram  2 , Nafis Haider  3 , Rafeeque Ahmed  4
Affiliations

Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission

Faizan Mazhar et al. Case Rep Med. 2016.

Abstract

Antipsychotic and antidepressant are often used in combination for the treatment of neuropsychiatric disorders. The concomitant use of antipsychotic and/or antidepressant with drugs that may interact can lead to rare, life-threatening conditions such as serotonin syndrome and neuroleptic malignant syndrome. We describe a patient who has a history of taking two offending drugs that interact with drugs given during the course of hospital treatment which leads to the development of serotonin syndrome overlapped with neuroleptic malignant syndrome. The physician should be aware that both NMS and SS can appear as overlapping syndrome especially when patients use a combination of both antidepressants and antipsychotics.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Carbone J. R. The neuroleptic malignant and serotonin syndromes. Emergency Medicine Clinics of North America. 2000;18(2):317–325. doi: 10.1016/s0733-8627(05)70127-9. - DOI - PubMed
    1. Cassidy E., O'Kearne V. Neuroleptic malignant syndrome after venlafaxine. The Lancet. 2000;355:2164–2165. - PubMed
    1. Tsai H.-C., Kuo P.-H., Yang P.-C. Fever, consciousness disturbance, and muscle rigidity in a 68-year-old man with depressive disorder. Chest. 2003;124(4):1598–1601. doi: 10.1378/chest.124.4.1598. - DOI - PubMed
    1. Trollor J. N., Chen X., Sachdev P. S. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23(6):477–492. doi: 10.2165/00023210-200923060-00003. - DOI - PubMed
    1. Dunkley E. J. C., Isbister G. K., Sibbritt D., Dawson A. H., Whyte I. M. The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. Quarterly Journal of Medicine. 2003;96(9):635–642. doi: 10.1093/qjmed/hcg109. - DOI - PubMed

LinkOut - more resources